Ground-breaking research for asthma sufferers

In the region of half a million UK asthma sufferers could benefit from a revolutionary new treatment that could dramatically reduce the complications caused by common cold viral infections*. It is the first time a treatment has been found to work on this, the risk most commonly associated with of asthma hospitalisations. In this trial conducted by Synairgen, the inhaled drug (SNG001) significantly reduced asthma symptoms during the critical first week of infection and reduced the number of exacerbations...

Keep reading at easier.com



Silver goodies at Asthma UK House and Garden Fair

Beautiful fairytale-inspired jewellery by local silversmith Rebecca Ilett will form a dazzling display at this year’s House and Garden Fair in aid of Asthma UK...

Keep reading at cambridge-news.co.uk



MediciNova To Release Asthma And COPD Trial Results In Q2

MediciNova (MNOV) expects to release results from two clinical trials in the current second quarter with its lead drug candidate, MN-221, opening the door to a possible pivotal trial...

Keep reading at seekingalpha.com